Key highlights from Laurus Labs Limited (LAURUSLABS) Q2 FY24 Earnings Concall Q2 FY24 Results Revenue declined 22% year-on-year to INR1,224 crores.. EBITDA
Laurus Labs Limited Q2 FY24 Earnings Conference Call Insights
Categories
Pharmaceutical
Alkem Laboratories: Good times ahead?
“This growth was primarily fueled by strong performance of our business in international markets wherein we have crossed Rs.1000 Crores for the
Procter & Gamble Health Ltd Q1FY24; 27% fall in Profits
P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals
Panchsheel Organics Ltd Q1FY24; 3% fall in Profits
Panchsheel Organics Ltd is engaged in the business of manufacturing and trading of bulk drugs and intermediates. Financial Results: Panchsheel Organics Ltd
Panacea Biotec Ltd Q1FY24; 16% rise in Revenue
Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly listed in
Marksans Pharma Ltd Q1FY24; 17% rise in Profits
Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for Q1FY24 of
Pfizer Ltd Q1FY24; 185% rise in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Orchid Pharma Ltd Q1FY24; 40% rise in Revenue
Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It
Medico Remedies Ltd Q1FY24; 267% rise in Profits
Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations. Financial Results: Medico Remedies Ltd reported Revenues for Q1FY24 of ₹31.47
Lincoln Pharmaceuticals Ltd Q1FY24; 27% rise in Profits
Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products. Financial Results: Lincoln Pharmaceuticals Ltd
Natco Pharma Ltd Q1FY24; 31% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
Medicamen Biotech Ltd Q1FY24; 23% rise in Profits
Medicamen Biotech Ltd develops and markets a wide range of branded and generic formulations in the pharmaceutical industry. Financial Results: Medicamen Biotech
Piramal Pharma Ltd Q1FY24; 18% rise in Revenue
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract development and
Lupin Ltd Q1FY24; 29% rise in Revenue
Lupin is engaged in the business of Manufacture of Pharmaceuticals. Financial Results: Lupin Ltd reported Revenues for Q1FY24 of ₹4,814.00 Crores up
Neuland Laboratories Ltd Q1FY24; 520% rise in Profits
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland
Jagsonpal Pharmaceuticals Ltd Q1FY24; 156% rise in Profits
Jagsonpal Pharmaceuticals Ltd is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. It has operations in India and
Lyka Labs Ltd Q1FY24; 17% fall in Revenue
Lyka labs Ltd is a pharmaceutical company engaged in development, manufacturing and marketing of pharmaceutical products. It has a well-diversified business model
RPG Life Sciences Ltd Q1FY24; 22% rise in Profits
RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in
Laurus Labs Ltd Q1FY24; 94% fall in Profits
Laurus Labs is principally engaged in offering a broad and integrated portfolio of Active Pharmaceuticals Ingredients (API) including intermediates, Generic Finished dosage
Novartis India Ltd Q1FY24; 62% fall in Profits
Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.It imports various medicines to India from
Aurobindo Pharma: Driving Growth in the Pharmaceutical Industry
Stock Data: TickerNSE: AUROPHARMAExchangeNSEIndustryPHARMACEUTICALS Price Performance: Last 5 Days+2.46%YTD+54.04%Last 12 Months+26.40% Company Description: Aurobindo, a company based in Hyderabad since 1986, focuses